Ethyl Acetate

Ethyl Acetate

SCHEMBL1643383

CCCC(CC)CC(=O)OC.CCOC(C)=O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
LMNA P02545 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MGAM O43451 2/20 0.36
GAA P10253 2/20 0.36
SI P14410 2/20 0.36
MGAM2 Q2M2H8 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
TSHR P16473 4/20 0.36
CYP3A4 P08684 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ATM Q13315 1/20 0.36
RECQL P46063 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
FAAH O00519 1/20 0.31
ZDHHC7 Q9NXF8 1/20 0.31
CA12 O43570 1/20 0.31
CA14 Q9ULX7 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL2533445 0.90 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10MGAMGAA
SCHEMBL26802498 0.88 CA2 (0.39) ALDH1A1HSD17B10MGAMGAASI
SCHEMBL2959866 0.82 MGAM (0.44) ALDH1A1LMNAHSD17B10MGAMGAA
SCHEMBL11356150 0.80 TSHR (0.42) ALDH1A1HSD17B10MGAMGAASI
SCHEMBL13506382 0.80 TSHR (0.42) ALDH1A1HSD17B10MGAMGAASI
SCHEMBL14022813 0.77 CYP3A4 (0.53) ALDH1A1CA1CA2TSHRCYP3A4
SCHEMBL16256492 0.75 TSHR (0.46) ALDH1A1LMNAHSD17B10MGAMGAA
SCHEMBL7888718 0.75 TSHR (0.46) ALDH1A1LMNAHSD17B10MGAMGAA
SCHEMBL2255277 0.75 TSHR (0.47) ALDH1A1LMNAHSD17B10CA1CA2
Ethyl Acetate SCHEMBL6828557 0.75 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420694-B2 Pyrrolidin-2-one derivatives as androgen receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-04-16 US disclosed
US-20110098336-A1 PYRROLIDIN-2-ONE DERIVATIVES AS ANDROGEN RECEPTOR MODULATOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098336-A1 PYRROLIDIN-2-ONE DERIVATIVES AS ANDROGEN RECEPTOR MODULATOR AR, NR5A1, SHBG ALDH1A1 788/4885LMNA 4654/4885HSD17B10 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.